Securities Act claims allege AEVEX’s IPO registration statement described a 180-day lock-up as binding while a plan to waive it for a secondary offering was allegedly already in place, a disclosure gap tied to roughly $900 million in lost market value.

NEW YORK, Sept. 23, 2026 /PRNewswire/ — Levi & Korsinsky, LLP announces that a securities class action has been filed against AEVEX Corp. (NYSE: AVEX) on behalf of investors who purchased shares in or traceable to the Company’s April 17, 2026 initial public offering and on behalf of purchasers between April 17, 2026 and June 4, 2026. Find out if you might qualify for recovery. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

AVEX Class A shares fell approximately 16% on June 2, 2026 and a further 7% on June 5, 2026, erasing roughly $900 million in market capitalization. Motions for lead plaintiff must be filed with the Court by October 20, 2026.

The Alleged Registration Statement Misrepresentations

Sections 11, 12, and 15 of the Securities Act of 1933 impose liability for untrue statements of material fact in a registration statement and for omissions of facts required to make those statements not misleading. The action, pending in the United States District Court for the Southern District of California, contends the IPO Offering Documents told purchasers that shares owned by the Company’s principal stockholder could not be sold or converted for 180 days, through October 13, 2026, while a pre-arranged plan to waive that restriction was allegedly already understood among the Company, its private equity owner, and the underwriter representatives.

What the Registration Statement Allegedly Misrepresented

• The permanence of the 180-day lock-up on Class A shares held by the controlling stockholder
• The framing of the Registration Rights Agreement as operative only “following… the expiration of any related lock-up period”
• The existence, as pleaded, of an understanding to release lock-up restrictions well before their stated expiration
• The likelihood that a secondary offering of 8,000,000 shares would be brought to market weeks after the IPO
• The allocation of secondary offering economics, with net proceeds of $207.9 million allegedly directed entirely to the principal stockholder

Alleged IPO Proceeds and Defendant Motivation

The IPO generated approximately $346 million for the Company and more than $22 million in fees for the underwriters. Plaintiffs allege that the June 1, 2026 registration statement, filed 41 days after the IPO priced, and the June 5, 2026 final prospectus corrected the prior offering disclosures and that purchasers who acquired shares under those documents were damaged as a result.

“The Securities Act provides important protections for investors who purchase in a registered offering, including the right to accurate disclosure about restrictions on insider sales. The complaint raises the question of whether purchasers were given a complete picture of the lock-up before they committed capital.” — Joseph E. Levi, Esq.

Submit your information now or call (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services’ Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors. Investors who suffered losses have until October 20, 2026 to seek appointment as lead plaintiff.

Frequently Asked Questions About the AVEX Lawsuit

Q: Who is eligible to join the AVEX investor lawsuit? A: Investors who purchased AVEX stock or securities between April 17, 2026 and June 4, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: What is the AVEX lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is October 20, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.

Q: What specific misstatements does the AVEX lawsuit allege? A: The complaint alleges AEVEX Corp. made materially false or misleading statements regarding the permanence of the 180-day lock-up restricting its controlling stockholder from selling shares until October 13, 2026 during the Class Period. When the waiver of those lock-up restrictions and the secondary offering were disclosed, the stock price declined sharply.

Q: What court was the AVEX class action filed in? A: The case was filed in the United States District Court for the Southern District of California, governed by the Private Securities Litigation Reform Act of 1995.

Q: What do AVEX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible as an absent class member.

Q: What documents do I need to to submit my information? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my AVEX shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor’s country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avex-upcoming-deadline-levi–korsinsky-alerts-aevex-corp-stockholders-of-securities-class-action—contact-the-firm-302887169.html

SOURCE Levi & Korsinsky, LLP